Investigating the Possibility of Biomarkers in Order to Correctly Prescribe ADCs Dependent on Individual Patient Response to Toxicities
Time: 12:45 pm
day: Conference Day 1
Details:
Discovering the possibility of biomarkers to understand amount/application of ADC dosing dependent on patient screening results
Looking at patient-dependent liabilities to toxicities to decide on whether the prescription of an ADC would be beneficial
Identifying which biomarkers are indicative of higher toxicity levels
